期刊
CARDIOVASCULAR PATHOLOGY
卷 22, 期 1, 页码 91-95出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.carpath.2012.03.005
关键词
Fibrosis; Thrombospondin; Cardiac repair; Cell transplantation; Scar; Angiogenesis
资金
- National Institutes of Health [HL64387, HL94374, HL61553, HL84642, AR45418, T32 EB001650, T32 GM007266]
- University of Washington's Mouse Metabolic Phenotyping Center [DK076126]
- ARCS Foundation
- Poncin Scholarship
Background: Fibrosis around cardiac cell injections represents an obstacle to graft integration in cell-based cardiac repair. Thrombospondin-2 (TSP-2) is a pro-fibrotic, anti-angiogenic matricellular protein and an attractive target for therapeutic knockdown to improve cardiac graft integration and survival. Methods: We used a TSP-2 knockout (KO) mouse in conjunction with a fetal murine cardiomyocyte grafting model to evaluate the effects of a lack of TSP-2 on fibrosis, vascular density, and graft size in the heart. Results: Two weeks after grafting in the uninjured heart, fibrosis area was reduced 4.5-fold in TSP-2 KO mice, and the thickness of the pen-graft scar capsule was reduced sevenfold compared to wild-type (WO. Endothelial cell density in the pen-graft region increased 2.5-fold in the absence of TSP-2, and cardiomyocyte graft size increased by 46% in TSP-2 KO hearts. Conclusions: TSP-2 is a key regulator of fibrosis and angiogenesis following cell grafting in the heart, and its absence promotes better graft integration, vascularization, and survival. (c) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据